Immunoglobulin Light Chain Amyloidosis

• CLINICAL_TRIALS research · 2025-12-17
  Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion [Phase 1, Phase 2]

  A Phase 1/2 clinical trial from AbbVie evaluating intravenous Etentamig (ABBV-383) in adults with AL amyloidosis; the study is currently rec…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

  This clinical trial is evaluating an 18F-labeled PET imaging tracer called [18F]FT8 for amyloidosis, including cardiac amyloidosis. The stud…

• CLINICAL_TRIALS trial_result · 2023-03-20
  Clinical Trial Update: Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis [Phase 3]

  A Phase 3 trial reports that probiotic supplementation reduces GI symptoms during therapy and improves therapeutic response in immunoglobuli…

• CLINICAL_TRIALS trial_result · 2020-11-03
  Clinical Trial Update: Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis [Phase 4]

  A Phase 4 trial comparing BTD and BCD regimens for Immunoglobulin Light-Chain Amyloidosis.

• CLINICAL_TRIALS withdrawal · 2018-03-02
  Clinical Trial Update: Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis [Phase 2]

  A Phase 2 trial evaluating ibrutinib with or without bortezomib and dexamethasone for relapsed or refractory immunoglobulin light chain amyl…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-06-30
  Clinical Trial Update: Bortezomib for Immunoglobulin Light Chain(AL) Amyloidosis

  A clinical trial evaluating bortezomib for immunoglobulin light chain (AL) amyloidosis has completed.